Literature DB >> 21111063

CaMKII regulation of phospholamban and SR Ca2+ load.

Alicia Mattiazzi1, Evangelia G Kranias.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21111063      PMCID： PMC3081991          DOI： 10.1016/j.hrthm.2010.11.035

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  5 in total

1.  Calmodulin kinase II inhibition protects against structural heart disease.

Authors:  Rong Zhang; Michelle S C Khoo; Yuejin Wu; Yingbo Yang; Chad E Grueter; Gemin Ni; Edward E Price; William Thiel; Silvia Guatimosim; Long-Sheng Song; Ernest C Madu; Anisha N Shah; Tatiana A Vishnivetskaya; James B Atkinson; Vsevolod V Gurevich; Guy Salama; W J Lederer; Roger J Colbran; Mark E Anderson
Journal:  Nat Med       Date:  2005-03-27       Impact factor: 53.440

2.  Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart.

Authors:  C Mundiña-Weilenmann; L Vittone; M Ortale; G C de Cingolani; A Mattiazzi
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

3.  Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice.

Authors:  Tong Zhang; Tao Guo; Shikha Mishra; Nancy D Dalton; Evangelia G Kranias; Kirk L Peterson; Donald M Bers; Joan Heller Brown
Journal:  Circ Res       Date:  2009-12-03       Impact factor: 17.367

4.  The signalling pathway of CaMKII-mediated apoptosis and necrosis in the ischemia/reperfusion injury.

Authors:  Margarita A Salas; Carlos A Valverde; Gina Sánchez; Matilde Said; Jesica S Rodriguez; Enrique L Portiansky; Marcia A Kaetzel; John R Dedman; Paulina Donoso; Evangelia G Kranias; Alicia Mattiazzi
Journal:  J Mol Cell Cardiol       Date:  2010-01-06       Impact factor: 5.000

5.  Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.

Authors:  W Luo; I L Grupp; J Harrer; S Ponniah; G Grupp; J J Duffy; T Doetschman; E G Kranias
Journal:  Circ Res       Date:  1994-09       Impact factor: 17.367
  5 in total
  13 in total

1.  Constitutive BDNF/TrkB signaling is required for normal cardiac contraction and relaxation.

Authors:  Ning Feng; Sabine Huke; Guangshuo Zhu; Carlo G Tocchetti; Sa Shi; Takeshi Aiba; Nina Kaludercic; Donald B Hoover; Sarah E Beck; Joseph L Mankowski; Gordon F Tomaselli; Donald M Bers; David A Kass; Nazareno Paolocci
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

Review 2.  Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias.

Authors:  Paari Dominic Swaminathan; Anil Purohit; Thomas J Hund; Mark E Anderson
Journal:  Circ Res       Date:  2012-06-08       Impact factor: 17.367

Review 3.  Structure-function relationships and modifications of cardiac sarcoplasmic reticulum Ca2+-transport.

Authors:  M Nusier; A K Shah; N S Dhalla
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

4.  The multifunctional Ca(2+)/calmodulin-dependent protein kinase II delta (CaMKIIδ) phosphorylates cardiac titin's spring elements.

Authors:  Carlos G Hidalgo; Charles S Chung; Chandra Saripalli; Mei Methawasin; Kirk R Hutchinson; George Tsaprailis; Siegfried Labeit; Alicia Mattiazzi; Henk L Granzier
Journal:  J Mol Cell Cardiol       Date:  2012-12-05       Impact factor: 5.000

5.  Synthetic phosphopeptides enable quantitation of the content and function of the four phosphorylation states of phospholamban in cardiac muscle.

Authors:  Naa-Adjeley D Ablorh; Xiaoqiong Dong; Zachary M James; Qiang Xiong; Jianyi Zhang; David D Thomas; Christine B Karim
Journal:  J Biol Chem       Date:  2014-09-04       Impact factor: 5.157

6.  CaMKII effects on inotropic but not lusitropic force frequency responses require phospholamban.

Authors:  Yiming Wu; Elizabeth D Luczak; Eun-Jeong Lee; Carlos Hidalgo; Jinying Yang; Zhan Gao; Jingdong Li; Xander H T Wehrens; Henk Granzier; Mark E Anderson
Journal:  J Mol Cell Cardiol       Date:  2012-07-11       Impact factor: 5.000

Review 7.  The promise of CaMKII inhibition for heart disease: preventing heart failure and arrhythmias.

Authors:  B Daan Westenbrink; Andrew G Edwards; Andrew D McCulloch; Joan Heller Brown
Journal:  Expert Opin Ther Targets       Date:  2013-06-24       Impact factor: 6.902

8.  A Memory Molecule, Ca(2+)/Calmodulin-Dependent Protein Kinase II and Redox Stress; Key Factors for Arrhythmias in a Diseased Heart.

Authors:  Young-Hwan Song
Journal:  Korean Circ J       Date:  2013-03       Impact factor: 3.243

Review 9.  CaMKII-dependent responses to ischemia and reperfusion challenges in the heart.

Authors:  James R Bell; Martin Vila-Petroff; Lea M D Delbridge
Journal:  Front Pharmacol       Date:  2014-05-06       Impact factor: 5.810

10.  Inhibition of CaMKII does not attenuate cardiac hypertrophy in mice with dysfunctional ryanodine receptor.

Authors:  Asima Chakraborty; Daniel A Pasek; Tai-Qin Huang; Angela C Gomez; Naohiro Yamaguchi; Mark E Anderson; Gerhard Meissner
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.